2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease.

0 This document was approved by the American College of Cardiology Clin Advisory and Coordinating Committee, and the American Heart Association The American College of Cardiology requests that this document be cited ZD, Hahn EJ, Himmelfarb CD, Khera A, Lloyd-Jones D, McEvoy JW, Michos ED Ziaeian B. 2019 ACC/AHA guideline on the primary prevention of cardiovascu Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol 20 This article has been copublished in Circulation. Copies: This document is available on the websites of the American C (professional.heart.org/). For copies of this document, please contact the El elsevier.com). Permissions: Multiple copies, modification, alteration, enhancement, and permission of the American College of Cardiology. Requests may be comple copyright/permissions). Michael D. Miedema, MD, MPH* Daniel Muñoz, MD, MPA, FACC* Sidney C. Smith, JR, MD, MACC, FAHA* Salim S. Virani, MD, PHD, FACC, FAHA* Kim A. Williams, SR, MD, MACC, FAHA* Joseph Yeboah, MD, MS, FACC, FAHA* Boback Ziaeian, MD, PHD, FACC, FAHAx

[1]  Daniel E Forman,et al.  2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. , 2019, Journal of the American College of Cardiology.

[2]  Deepak L. Bhatt,et al.  Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes , 2019, The New England journal of medicine.

[3]  Marc P. Bonaca,et al.  SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials , 2019, The Lancet.

[4]  N. Rigotti,et al.  2018 ACC Expert Consensus Decision Pathway on Tobacco Cessation Treatment: A Report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. , 2018, Journal of the American College of Cardiology.

[5]  L. Shaw,et al.  Impact of Statins on Cardiovascular Outcomes Following Coronary Artery Calcium Scoring. , 2018, Journal of the American College of Cardiology.

[6]  D. Mozaffarian,et al.  Association of dairy intake with cardiovascular disease and mortality in 21 countries from five continents (PURE): a prospective cohort study , 2018, The Lancet.

[7]  D. Reboussin,et al.  Systematic Review for the 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines , 2018, Circulation.

[8]  R. Collins,et al.  Effects of Aspirin for Primary Prevention in Persons with Diabetes Mellitus , 2018, The New England journal of medicine.

[9]  P. Ridker Should Aspirin Be Used for Primary Prevention in the Post-Statin Era? , 2018, The New England journal of medicine.

[10]  Diane M. Miller,et al.  Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial. , 2018, Lancet.

[11]  P. Barbillon,et al.  Patterns of plant and animal protein intake are strongly associated with cardiovascular mortality: the Adventist Health Study-2 cohort. , 2018, International journal of epidemiology.

[12]  Carrie D. Patnode,et al.  Behavioral and Pharmacotherapy Weight Loss Interventions to Prevent Obesity-Related Morbidity and Mortality in Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force , 2018, JAMA.

[13]  Suzanne G. Orchard,et al.  Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly , 2018, The New England journal of medicine.

[14]  L. Tokgozoglu,et al.  Impact of Lipids on Cardiovascular Health: JACC Health Promotion Series. , 2018, Journal of the American College of Cardiology.

[15]  P. Rothwell,et al.  Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial , 2018, The Lancet.

[16]  Samia Mora,et al.  Evaluation of the Pooled Cohort Risk Equations for Cardiovascular Risk Prediction in a Multiethnic Cohort From the Women’s Health Initiative , 2018, JAMA internal medicine.

[17]  Jennifer J. Otten,et al.  Low-Calorie Sweetened Beverages and Cardiometabolic Health: A Science Advisory From the American Heart Association , 2018, Circulation.

[18]  E. Rimm,et al.  Dietary carbohydrate intake and mortality: a prospective cohort study and meta-analysis , 2018, The Lancet. Public health.

[19]  V. Fuster,et al.  Cardiovascular Health Promotion: An Issue That Can No Longer Wait. , 2018, Journal of the American College of Cardiology.

[20]  N. Cook,et al.  Effects of aspirin on risks of vascular events and cancer according to bodyweight and dose: analysis of individual patient data from randomised trials , 2018, The Lancet.

[21]  P. Greenland,et al.  Erectile Dysfunction as an Independent Predictor of Future Cardiovascular Events. , 2018, Circulation.

[22]  J. Ige,et al.  Built and natural environment planning principles for promoting health: an umbrella review , 2018, BMC Public Health.

[23]  M. Paasche-Orlow,et al.  Health Literacy and Cardiovascular Disease: Fundamental Relevance to Primary and Secondary Prevention: A Scientific Statement From the American Heart Association. , 2018, Circulation.

[24]  K. Watson,et al.  Atherosclerotic Cardiovascular Disease in South Asians in the United States: Epidemiology, Risk Factors, and Treatments: A Scientific Statement From the American Heart Association. , 2018, Circulation.

[25]  D. Mozaffarian,et al.  Seafood Long-Chain n-3 Polyunsaturated Fatty Acids and Cardiovascular Disease: A Science Advisory From the American Heart Association , 2018, Circulation.

[26]  R. Kronmal,et al.  Ten-year association of coronary artery calcium with atherosclerotic cardiovascular disease (ASCVD) events: the multi-ethnic study of atherosclerosis (MESA) , 2018, European heart journal.

[27]  M. Hernán,et al.  Primary Prevention of Cardiovascular Disease with a Mediterranean Diet Supplemented with Extra‐Virgin Olive Oil or Nuts , 2018, The New England journal of medicine.

[28]  S. Basu,et al.  Clinical Implications of Revised Pooled Cohort Equations for Estimating Atherosclerotic Cardiovascular Disease Risk , 2018, Annals of Internal Medicine.

[29]  J. Manson,et al.  Influence of Lifestyle on Incident Cardiovascular Disease and Mortality in Patients With Diabetes Mellitus. , 2018, Journal of the American College of Cardiology.

[30]  Dustin M. Thomas,et al.  Treatment in a preventive cardiology clinic utilizing advanced practice providers effectively closes atherosclerotic cardiovascular disease risk‐management gaps among a primary‐prevention population compared with a propensity‐matched primary‐care cohort: A team‐based care model and its impact on lip , 2018, Clinical cardiology.

[31]  David M. Reboussin,et al.  Systematic Review for the 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines , 2018, Hypertension.

[32]  R. D'Agostino,et al.  Cardiovascular Risk Prediction Functions Underestimate Risk in HIV Infection , 2018, Circulation.

[33]  A. Perzynski,et al.  Accuracy of Cardiovascular Risk Prediction Varies by Neighborhood Socioeconomic Position , 2018, Annals of Internal Medicine.

[34]  S. Stavrakis,et al.  Obesity is associated with incident atrial fibrillation independent of gender: A meta‐analysis , 2018, Journal of cardiovascular electrophysiology.

[35]  Emmanuel Stamatakis,et al.  How does light-intensity physical activity associate with adult cardiometabolic health and mortality? Systematic review with meta-analysis of experimental and observational studies , 2018, British Journal of Sports Medicine.

[36]  P. Östergren,et al.  Reducing health inequalities with interventions targeting behavioral factors among individuals with low levels of education - A rapid review , 2018, PloS one.

[37]  L. Caulfield,et al.  Healthy Plant-Based Diets Are Associated with Lower Risk of All-Cause Mortality in US Adults. , 2018, The Journal of nutrition.

[38]  James Woodcock,et al.  Sedentary behaviour and risk of all-cause, cardiovascular and cancer mortality, and incident type 2 diabetes: a systematic review and dose response meta-analysis , 2018, European Journal of Epidemiology.

[39]  Francesca N. Delling,et al.  Heart Disease and Stroke Statistics—2018 Update: A Report From the American Heart Association , 2018, Circulation.

[40]  W. Kraus,et al.  Moderate‐to‐Vigorous Physical Activity and All‐Cause Mortality: Do Bouts Matter? , 2018, Journal of the American Heart Association.

[41]  Steven Shea,et al.  Basic vs More Complex Definitions of Family History in the Prediction of Coronary Heart Disease: The Multi‐Ethnic Study of Atherosclerosis , 2018, Mayo Clinic proceedings.

[42]  R. Brook,et al.  2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. , 2018, Journal of the American Society of Hypertension : JASH.

[43]  Jiang He,et al.  Comparative Effectiveness of Implementation Strategies for Blood Pressure Control in Hypertensive Patients , 2018, Annals of Internal Medicine.

[44]  R. Guthrie Canagliflozin and cardiovascular and renal events in type 2 diabetes , 2018, Postgraduate medicine.

[45]  Daniel W. Jones,et al.  Potential US Population Impact of the 2017 ACC/AHA High Blood Pressure Guideline , 2018, Circulation.

[46]  Deepak L. Bhatt,et al.  Cardiovascular Risk and Statin Eligibility of Young Adults After an MI: Partners YOUNG-MI Registry. , 2017, Journal of the American College of Cardiology.

[47]  Michael D. Garber,et al.  Routine Assessment and Promotion of Physical Activity in Healthcare Settings: A Scientific Statement From the American Heart Association , 2018, Circulation.

[48]  Guijing Wang,et al.  Cost-effectiveness Analyses of Antihypertensive Medicines: A Systematic Review , 2017, American journal of preventive medicine.

[49]  M. Budoff,et al.  Coronary Artery Calcium Score for Long-term Risk Classification in Individuals With Type 2 Diabetes and Metabolic Syndrome From the Multi-Ethnic Study of Atherosclerosis , 2017, JAMA cardiology.

[50]  C. Yancy,et al.  Cardiovascular Health in African Americans: A Scientific Statement From the American Heart Association , 2017, Circulation.

[51]  E. Wan,et al.  Five-Year Effectiveness of the Multidisciplinary Risk Assessment and Management Programme–Diabetes Mellitus (RAMP-DM) on Diabetes-Related Complications and Health Service Uses—A Population-Based and Propensity-Matched Cohort Study , 2017, Diabetes Care.

[52]  A. Avenell,et al.  Effects of weight loss interventions for adults who are obese on mortality, cardiovascular disease, and cancer: systematic review and meta-analysis , 2017, British Medical Journal.

[53]  Michael J. Zaleha,et al.  Associations of fats and carbohydrate intake with cardiovascular disease and mortality in 18 countries from five continents (PURE): a prospective cohort study. , 2017, Lancet.

[54]  Craig M. Hales,et al.  Prevalence of Obesity Among Adults and Youth: United States, 2015-2016. , 2017, NCHS data brief.

[55]  L. Goldman,et al.  Evaluating the Impact and Cost-Effectiveness of Statin Use Guidelines for Primary Prevention of Coronary Heart Disease and Stroke , 2017, Circulation.

[56]  A. Verma,et al.  Race and Socioeconomic Differences Associated With Changes in Statin Eligibility Under the 2013 American College of Cardiology/American Heart Association Cholesterol Guidelines , 2017, Circulation. Cardiovascular quality and outcomes.

[57]  M. Zawistowski,et al.  The Veterans Affairs Cardiac Risk Score: Recalibrating the Atherosclerotic Cardiovascular Disease Score for Applied Use , 2017, Medical care.

[58]  O. Franco,et al.  Association of Coronary Artery Calcium Score vs Age With Cardiovascular Risk in Older Adults: An Analysis of Pooled Population-Based Studies , 2017, JAMA cardiology.

[59]  S. Griffin,et al.  Impact of metformin on cardiovascular disease: a meta-analysis of randomised trials among people with type 2 diabetes , 2017, Diabetologia.

[60]  M. Budoff,et al.  The Identification of Calcified Coronary Plaque Is Associated With Initiation and Continuation of Pharmacological and Lifestyle Preventive Therapies: A Systematic Review and Meta-Analysis. , 2017, JACC. Cardiovascular imaging.

[61]  H. Krumholz Treatment of Cholesterol in 2017. , 2017, JAMA.

[62]  L. Shaw,et al.  Implications of Coronary Artery Calcium Testing for Treatment Decisions Among Statin Candidates According to the ACC/AHA Cholesterol Management Guidelines: A Cost-Effectiveness Analysis. , 2017, JACC. Cardiovascular imaging.

[63]  Susan Redline,et al.  Insomnia and Risk of Cardiovascular Disease. , 2017, Chest.

[64]  J. Manson,et al.  Healthful and Unhealthful Plant-Based Diets and the Risk of Coronary Heart Disease in U.S. Adults. , 2017, Journal of the American College of Cardiology.

[65]  Mathew G. Wilson,et al.  Prevalence of Subclinical Coronary Artery Disease in Masters Endurance Athletes With a Low Atherosclerotic Risk Profile , 2017, Circulation.

[66]  P. Whelton,et al.  Systolic Blood Pressure Reduction and Risk of Cardiovascular Disease and Mortality: A Systematic Review and Network Meta-analysis , 2017, JAMA cardiology.

[67]  Carrie D. Patnode,et al.  Behavioral Counseling to Promote a Healthful Diet and Physical Activity for Cardiovascular Disease Prevention in Adults Without Known Cardiovascular Disease Risk Factors: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force , 2017, JAMA.

[68]  S. Gabriel,et al.  Rheumatoid arthritis-specific cardiovascular risk scores are not superior to general risk scores: a validation analysis of patients from seven countries , 2017, Rheumatology.

[69]  Jeannie K. Lee,et al.  Impact of Diabetes Care by Pharmacists as Part of Health Care Team in Ambulatory Settings: A Systematic Review and Meta-analysis , 2017, The Annals of pharmacotherapy.

[70]  S. Bangalore,et al.  Optimal Systolic Blood Pressure Target After SPRINT: Insights from a Network Meta-Analysis of Randomized Trials. , 2017, The American journal of medicine.

[71]  Tamar S. Polonsky,et al.  Hospital Admissions for Myocardial Infarction and Stroke Before and After the Trans-Fatty Acid Restrictions in New York , 2017, JAMA cardiology.

[72]  J. Lima,et al.  Subclinical Atherosclerosis, Statin Eligibility, and Outcomes in African American Individuals: The Jackson Heart Study , 2017, JAMA cardiology.

[73]  D. Alley,et al.  Standardized Screening for Health-Related Social Needs in Clinical Settings: The Accountable Health Communities Screening Tool , 2017 .

[74]  J. Hartikainen,et al.  Association of objectively measured sedentary behaviour and physical activity with cardiovascular disease risk , 2017, European journal of preventive cardiology.

[75]  P. Whelton,et al.  Using Predicted Cardiovascular Disease Risk in Conjunction With Blood Pressure to Guide Antihypertensive Medication Treatment. , 2017, Journal of the American College of Cardiology.

[76]  Yiming Zhao,et al.  Lower Extremity Peripheral Arterial Disease Is an Independent Predictor of Coronary Heart Disease and Stroke Risks in Patients with Type 2 Diabetes Mellitus in China , 2017, International journal of endocrinology.

[77]  J. Attia,et al.  Effects of education and income on cardiovascular outcomes: A systematic review and meta-analysis , 2017, European journal of preventive cardiology.

[78]  M. Golzarand,et al.  The bariatric surgery and weight losing: a meta-analysis in the long- and very long-term effects of laparoscopic adjustable gastric banding, laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy on weight loss in adults , 2017, Surgical Endoscopy.

[79]  C. Lewis,et al.  Association of Coronary Artery Calcium in Adults Aged 32 to 46 Years With Incident Coronary Heart Disease and Death , 2017, JAMA cardiology.

[80]  M. McCullough,et al.  Paleolithic and Mediterranean Diet Pattern Scores Are Inversely Associated with All-Cause and Cause-Specific Mortality in Adults. , 2017, The Journal of nutrition.

[81]  V. Fuster,et al.  Evaluation of the Pooled Cohort Equations for Prediction of Cardiovascular Risk in a Contemporary Prospective Cohort. , 2017, The American journal of cardiology.

[82]  D. Mozaffarian,et al.  Association Between Dietary Factors and Mortality From Heart Disease, Stroke, and Type 2 Diabetes in the United States , 2017, JAMA.

[83]  J. Gornbein,et al.  Increased Cardiac Sympathetic Activity and Oxidative Stress in Habitual Electronic Cigarette Users: Implications for Cardiovascular Risk , 2017, JAMA cardiology.

[84]  D. Goff,et al.  Performance of the Atherosclerotic Cardiovascular Disease Pooled Cohort Risk Equations by Social Deprivation Status , 2017, Journal of the American Heart Association.

[85]  D. Lloyd‐Jones,et al.  Global Risk Assessment to Guide Blood Pressure Management in Cardiovascular Disease Prevention , 2017, Hypertension.

[86]  Paige L. Williams,et al.  Preterm Delivery and Maternal Cardiovascular Disease in Young and Middle-Aged Adult Women , 2017, Circulation.

[87]  G. Lippi,et al.  Statins for Primary Prevention of Cardiovascular Disease. , 2017, Trends in pharmacological sciences.

[88]  Raimund Erbel,et al.  CAC Score Improves Coronary and CV Risk Assessment Above Statin Indication by ESC and AHA/ACC Primary Prevention Guidelines. , 2017, JACC. Cardiovascular imaging.

[89]  J. Rehm,et al.  The effect of a reduction in alcohol consumption on blood pressure: a systematic review and meta-analysis. , 2017, The Lancet. Public health.

[90]  Seth A. Berkowitz,et al.  Addressing Unmet Basic Resource Needs as Part of Chronic Cardiometabolic Disease Management , 2017, JAMA internal medicine.

[91]  Richard D Moore,et al.  Assessing and Refining Myocardial Infarction Risk Estimation Among Patients With Human Immunodeficiency Virus: A Study by the Centers for AIDS Research Network of Integrated Clinical Systems , 2017, JAMA cardiology.

[92]  C. Chew‐Graham,et al.  Preeclampsia and Future Cardiovascular Health: A Systematic Review and Meta-Analysis , 2017, Circulation. Cardiovascular quality and outcomes.

[93]  Andy McEwen,et al.  National guidelines for smoking cessation in primary care: a literature review and evidence analysis , 2017, npj Primary Care Respiratory Medicine.

[94]  J. Lee,et al.  Assessment of Coronary Artery Calcium Scoring for Statin Treatment Strategy according to ACC/AHA Guidelines in Asymptomatic Korean Adults , 2016, Yonsei medical journal.

[95]  E. Falk,et al.  ACC/AHA guidelines superior to ESC/EAS guidelines for primary prevention with statins in non-diabetic Europeans: the Copenhagen General Population Study , 2016, European heart journal.

[96]  Gediminas Adomavicius,et al.  Use and Customization of Risk Scores for Predicting Cardiovascular Events Using Electronic Health Record Data , 2016, Journal of the American Heart Association.

[97]  Richard A. Kronmal,et al.  Risk score overestimation: the impact of individual cardiovascular risk factors and preventive therapies on the performance of the American Heart Association-American College of Cardiology-Atherosclerotic Cardiovascular Disease risk score in a modern multi-ethnic cohort , 2016, European heart journal.

[98]  P. Venugopal,et al.  Utility of Nontraditional Risk Markers in Atherosclerotic Cardiovascular Disease Risk Assessment , 2017 .

[99]  Laura Lovato,et al.  Effects of High Density Lipoprotein Raising Therapies on Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus, with or without Renal Impairment: The Action to Control Cardiovascular Risk in Diabetes Study , 2016, American Journal of Nephrology.

[100]  M. Woodward,et al.  Sex differences in the relationship between socioeconomic status and cardiovascular disease: a systematic review and meta-analysis , 2016, Journal of Epidemiology & Community Health.

[101]  N. Reichek,et al.  Collective impact of conventional cardiovascular risk factors and coronary calcium score on clinical outcomes with or without statin therapy: The St Francis Heart Study. , 2016, Atherosclerosis.

[102]  L. Groop,et al.  Sweetened beverage intake and risk of latent autoimmune diabetes in adults (LADA) and type 2 diabetes. , 2016, European journal of endocrinology.

[103]  E. Arias,et al.  Mortality in the United States, 2015. , 2016, NCHS data brief.

[104]  A. Kengne,et al.  Built Environment, Selected Risk Factors and Major Cardiovascular Disease Outcomes: A Systematic Review , 2016, PloS one.

[105]  O. Franco,et al.  Prevalence and Prognostic Implications of Coronary Artery Calcification in Low-Risk Women: A Meta-analysis. , 2016, JAMA.

[106]  Yuling Hong,et al.  Heart Disease and Cancer Deaths — Trends and Projections in the United States, 1969–2020 , 2016, Preventing chronic disease.

[107]  D. Angiolillo,et al.  Aspirin for Primary Cardiovascular Risk Prevention and Beyond in Diabetes Mellitus , 2016, Circulation.

[108]  Douglas K Owens,et al.  Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: US Preventive Services Task Force Recommendation Statement. , 2016, JAMA.

[109]  A. Schuler,et al.  Cost-effectiveness of Intensive Blood Pressure Management. , 2016, JAMA cardiology.

[110]  G. Francis,et al.  2016 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult. , 2016, The Canadian journal of cardiology.

[111]  A. Hoes,et al.  2016 ESC/EAS Guidelines for the Management of Dyslipidaemias. , 2016, European heart journal.

[112]  P. Greenland,et al.  Refining Statin Prescribing in Lower-Risk Individuals: Informing Risk/Benefit Decisions. , 2016, Journal of the American College of Cardiology.

[113]  Mingyang Song,et al.  Association of Animal and Plant Protein Intake With All-Cause and Cause-Specific Mortality. , 2016, JAMA internal medicine.

[114]  Jeffrey S. Gonzalez,et al.  Psychosocial factors in medication adherence and diabetes self-management: Implications for research and practice. , 2016, The American psychologist.

[115]  Xueli Yang,et al.  Predicting the 10-Year Risks of Atherosclerotic Cardiovascular Disease in Chinese Population: The China-PAR Project (Prediction for ASCVD Risk in China) , 2016, Circulation.

[116]  Brian A Ference,et al.  Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis. , 2016, JAMA.

[117]  Marie-France Hivert,et al.  Sedentary Behavior and Cardiovascular Morbidity and Mortality: A Science Advisory From the American Heart Association , 2016, Circulation.

[118]  Lawrence A Leiter,et al.  Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes. , 2016, The New England journal of medicine.

[119]  L. Räber,et al.  Prognosis of Patients With Familial Hypercholesterolemia After Acute Coronary Syndromes , 2016, Circulation.

[120]  G. Reboldi,et al.  More Versus Less Intensive Blood Pressure–Lowering StrategyNovelty and Significance , 2016 .

[121]  Nia Roberts,et al.  Quantifying the Association Between Physical Activity and Cardiovascular Disease and Diabetes: A Systematic Review and Meta‐Analysis , 2016, Journal of the American Heart Association.

[122]  V. Fuster,et al.  A Simple Disease-Guided Approach to Personalize ACC/AHA-Recommended Statin Allocation in Elderly People: The BioImage Study. , 2016, Journal of the American College of Cardiology.

[123]  John Everett Mumford,et al.  Physical activity and risk of breast cancer, colon cancer, diabetes, ischemic heart disease, and ischemic stroke events: systematic review and dose-response meta-analysis for the Global Burden of Disease Study 2013 , 2016, British Medical Journal.

[124]  P. Rothwell,et al.  Bleeding Risk with Long-Term Low-Dose Aspirin: A Systematic Review of Observational Studies , 2016, PloS one.

[125]  W. Hart-Davidson,et al.  Implementing shared decision making in federally qualified health centers, a quasi-experimental design study: the Office-Guidelines Applied to Practice (Office-GAP) program , 2016, BMC Health Services Research.

[126]  J. Manson,et al.  Aspirin for Primary Prevention of Atherosclerotic Cardiovascular Disease: Advances in Diagnosis and Treatment. , 2016, JAMA internal medicine.

[127]  J. Manson,et al.  Association of Specific Dietary Fats With Total and Cause-Specific Mortality. , 2016, JAMA internal medicine.

[128]  N. Stone,et al.  The ABCDs of Lifestyle Counseling. , 2016, JAMA cardiology.

[129]  P. Zhang,et al.  Prevalence of Central Obesity among Adults with Normal BMI and Its Association with Metabolic Diseases in Northeast China , 2016, PloS one.

[130]  M. Landray,et al.  Impact of renal function on the effects of LDL cholesterol lowering with statin-based regimens: a meta-analysis of individual participant data from 28 randomised trials. , 2016, The lancet. Diabetes & endocrinology.

[131]  J. Kastelein,et al.  Statins in Familial Hypercholesterolemia: Consequences for Coronary Artery Disease and All-Cause Mortality. , 2016, Journal of the American College of Cardiology.

[132]  D. Lloyd‐Jones,et al.  Long-Term Risk of Atherosclerotic Cardiovascular Disease in US Adults With the Familial Hypercholesterolemia Phenotype , 2016, Circulation.

[133]  B. Zee,et al.  Prospective Association between Diabetic Retinopathy and Cardiovascular Disease-A Systematic Review and Meta-analysis of Cohort Studies. , 2016, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[134]  R. Plodkowski,et al.  AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY COMPREHENSIVE CLINICAL PRACTICE GUIDELINES FOR MEDICAL CARE OF PATIENTS WITH OBESITY. , 2016, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[135]  E. Whitlock,et al.  Bleeding Risks With Aspirin Use for Primary Prevention in Adults: A Systematic Review for the U.S. Preventive Services Task Force , 2016, Annals of Internal Medicine.

[136]  E. Whitlock,et al.  Aspirin for the Primary Prevention of Cardiovascular Events: A Systematic Evidence Review for the U.S. Preventive Services Task Force , 2016, Annals of Internal Medicine.

[137]  N. Benowitz,et al.  Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial , 2016, The Lancet.

[138]  A. Bhatnagar Cardiovascular Perspective of the Promises and Perils of E-Cigarettes. , 2016, Circulation research.

[139]  J. Danesh,et al.  Diagnostic Yield and Clinical Utility of Sequencing Familial Hypercholesterolemia Genes in Patients With Severe Hypercholesterolemia. , 2016, Journal of the American College of Cardiology.

[140]  P. Loprinzi,et al.  Predictive Validity of the American College of Cardiology/American Heart Association Pooled Cohort Equations in Predicting All-Cause and Cardiovascular Disease-Specific Mortality in a National Prospective Cohort Study of Adults in the United States. , 2016, Mayo Clinic proceedings.

[141]  S. Adar,et al.  Neighborhood Environments and Incident Hypertension in the Multi-Ethnic Study of Atherosclerosis. , 2016, American journal of epidemiology.

[142]  Sue Hee Sung,et al.  Accuracy of the Atherosclerotic Cardiovascular Risk Equation in a Large Contemporary, Multiethnic Population. , 2016, Journal of the American College of Cardiology.

[143]  W. Maziak,et al.  A Systematic Review of the Prevalence and Outcomes of Ideal Cardiovascular Health in US and Non-US Populations. , 2016, Mayo Clinic proceedings.

[144]  J. Bosch,et al.  Updated Meta-Analysis of Aspirin in Primary Prevention of Cardiovascular Disease. , 2016, The American journal of medicine.

[145]  R. F. Walsh,et al.  Team-Based Hypertension Management to Improve Blood Pressure Control , 2016, Journal of primary care & community health.

[146]  J. Cigarroa,et al.  Further Evolution of the ACC/AHA Clinical Practice Guideline Recommendation Classification System: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. , 2016, Circulation.

[147]  S. Yusuf,et al.  Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease. , 2016, The New England journal of medicine.

[148]  S. Yusuf,et al.  Blood-Pressure Lowering in Intermediate-Risk Persons without Cardiovascular Disease. , 2016, The New England journal of medicine.

[149]  G. Parati,et al.  Effects of blood pressure lowering on outcome incidence in hypertension: 7. Effects of more vs. less intensive blood pressure lowering and different achieved blood pressure levels – updated overview and meta-analyses of randomized trials , 2016, Journal of hypertension.

[150]  Linnea A. Polgreen,et al.  Evaluation of Pharmacists' Work in a Physician‐Pharmacist Collaborative Model for the Management of Hypertension , 2016, Pharmacotherapy.

[151]  L. Banks,et al.  The Acute Risks of Exercise in Apparently Healthy Adults and Relevance for Prevention of Cardiovascular Events. , 2016, The Canadian journal of cardiology.

[152]  M. Fischereder,et al.  Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes. , 2016, The New England journal of medicine.

[153]  R. Kronmal,et al.  Role of Coronary Artery Calcium Score of Zero and Other Negative Risk Markers for Cardiovascular Disease: The Multi-Ethnic Study of Atherosclerosis (MESA) , 2016, Circulation.

[154]  L. Køber,et al.  Normal-Weight Central Obesity and Mortality Risk in Older Adults With Coronary Artery Disease. , 2016, Mayo Clinic proceedings.

[155]  G. Biondi‐Zoccai,et al.  Which Aspirin Dose and Preparation Is Best for the Long-Term Prevention of Cardiovascular Disease and Cancer? Evidence From a Systematic Review and Network Meta-Analysis. , 2016, Progress in cardiovascular diseases.

[156]  P. Ridker,et al.  Percent reduction in LDL cholesterol following high-intensity statin therapy: potential implications for guidelines and for the prescription of emerging lipid-lowering agents. , 2016, European heart journal.

[157]  Bo Carlberg,et al.  Effect of antihypertensive treatment at different blood pressure levels in patients with diabetes mellitus: systematic review and meta-analyses , 2016 .

[158]  Xiaohui Guo,et al.  Risk of non-fatal cardiovascular diseases in early-onset versus late-onset type 2 diabetes in China: a cross-sectional study. , 2016, The lancet. Diabetes & endocrinology.

[159]  N. Smart,et al.  Isometric exercise training for blood pressure management: a systematic review and meta-analysis to optimize benefit , 2016, Hypertension Research.

[160]  M. Woodward,et al.  Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis , 2016, The Lancet.

[161]  J. Prochaska,et al.  The Past, Present, and Future of Nicotine Addiction Therapy. , 2016, Annual Review of Medicine.

[162]  L. Afonso,et al.  Data on coronary artery calcium score performance and cardiovascular risk reclassification across gender and ethnicities , 2016, Data in brief.

[163]  D. Mozaffarian Dietary and Policy Priorities for Cardiovascular Disease, Diabetes, and Obesity: A Comprehensive Review , 2016, Circulation.

[164]  R. Hu,et al.  Cigarette Smoking and Electronic Cigarettes Use: A Meta-Analysis , 2016, International journal of environmental research and public health.

[165]  Thomas R Fanshawe,et al.  Combined pharmacotherapy and behavioural interventions for smoking cessation. , 2016, The Cochrane database of systematic reviews.

[166]  F. Porzsolt,et al.  Using machine learning to predict laboratory test results , 2016, Annals of clinical biochemistry.

[167]  C. Escobar Cervantes,et al.  [A randomized trial of intensive versus standard blood pressure control]. , 2016, Semergen.

[168]  A. Hoes,et al.  2016 European Guidelines on cardiovascular disease prevention in clinical practice. , 2016, Revista espanola de cardiologia.

[169]  Jennifer Y. Liu,et al.  Diabetes and Prior Coronary Heart Disease are Not Necessarily Risk Equivalent for Future Coronary Heart Disease Events , 2016, Journal of General Internal Medicine.

[170]  E. Falk,et al.  Primary Prevention With Statins: ACC/AHA Risk-Based Approach Versus Trial-Based Approaches to Guide Statin Therapy. , 2015, Journal of the American College of Cardiology.

[171]  D. Goff,et al.  Effect of Intensive Blood Pressure Lowering on Left Ventricular Hypertrophy in Patients With Diabetes Mellitus: Action to Control Cardiovascular Risk in Diabetes Blood Pressure Trial. , 2015, Hypertension.

[172]  Yu Xu,et al.  Risk of all-cause mortality and cardiovascular disease associated with secondhand smoke exposure: a systematic review and meta-analysis. , 2015, International journal of cardiology.

[173]  F. Hu,et al.  Relation of Smoking With Total Mortality and Cardiovascular Events Among Patients With Diabetes Mellitus: A Meta-Analysis and Systematic Review , 2015, Circulation.

[174]  C. Ayers,et al.  Dose–Response Relationship Between Physical Activity and Risk of Heart Failure: A Meta-Analysis , 2015, Circulation.

[175]  I. Mühlhauser,et al.  Informed shared decision-making programme on the prevention of myocardial infarction in type 2 diabetes: a randomised controlled trial , 2015, BMJ Open.

[176]  W. Qureshi,et al.  Risk Stratification for Primary Prevention of Coronary Artery Disease: Roles of C-Reactive Protein and Coronary Artery Calcium , 2015, Current Cardiology Reports.

[177]  R. Kronmal,et al.  10-Year Coronary Heart Disease Risk Prediction Using Coronary Artery Calcium and Traditional Risk Factors: Derivation in the MESA (Multi-Ethnic Study of Atherosclerosis) With Validation in the HNR (Heinz Nixdorf Recall) Study and the DHS (Dallas Heart Study). , 2015, Journal of the American College of Cardiology.

[178]  Harlan M. Krumholz,et al.  Implications of Coronary Artery Calcium Testing Among Statin Candidates According to American College of Cardiology/American Heart Association Cholesterol Management Guidelines: MESA (Multi-Ethnic Study of Atherosclerosis). , 2015, Journal of the American College of Cardiology.

[179]  D. Goff,et al.  Utility of Nontraditional Risk Markers in Individuals Ineligible for Statin Therapy According to the 2013 American College of Cardiology/American Heart Association Cholesterol Guidelines , 2015, Circulation.

[180]  Sung Hee Choi,et al.  The ACC/AHA 2013 pooled cohort equations compared to a Korean Risk Prediction Model for atherosclerotic cardiovascular disease. , 2015, Atherosclerosis.

[181]  Jillian T Henderson,et al.  Behavioral Counseling and Pharmacotherapy Interventions for Tobacco Cessation in Adults, Including Pregnant Women: A Review of Reviews for the U.S. Preventive Services Task Force , 2015, Annals of Internal Medicine.

[182]  J. Shikany,et al.  Southern Dietary Pattern Is Associated With Hazard of Acute Coronary Heart Disease in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study , 2015, Circulation.

[183]  George Davey-Smith,et al.  Social Determinants of Risk and Outcomes for Cardiovascular Disease: A Scientific Statement From the American Heart Association , 2015, Circulation.

[184]  P. O'Malley,et al.  Management of Dyslipidemia for Cardiovascular Disease Risk Reduction: Synopsis of the 2014 U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guideline , 2015, Annals of Internal Medicine.

[185]  Milton C Weinstein,et al.  Cost-effectiveness of 10-Year Risk Thresholds for Initiation of Statin Therapy for Primary Prevention of Cardiovascular Disease. , 2015, JAMA.

[186]  R. D'Agostino,et al.  Guideline-Based Statin Eligibility, Coronary Artery Calcification, and Cardiovascular Events. , 2015, JAMA.

[187]  D. Harvey,et al.  The risk and burden of smoking related heart disease mortality among young people in the United States , 2015, Tobacco induced diseases.

[188]  G. Grandes,et al.  Effectiveness of physical activity promotion interventions in primary care: A review of reviews. , 2015, Preventive medicine.

[189]  G. Filippatos,et al.  Risk of Heart Failure and Death After Prolonged Smoking Cessation: Role of Amount and Duration of Prior Smoking. , 2015, Circulation. Heart failure.

[190]  Dorothea K. Vafiadis,et al.  The National Physical Activity Plan: A Call to Action From the American Heart Association A Science Advisory From the American Heart Association , 2015, Circulation.

[191]  Jane A. Linderbaum,et al.  2015 ACC Health Policy Statement on Cardiovascular Team-Based Care and the Role of Advanced Practice Providers. , 2015, Journal of the American College of Cardiology.

[192]  L. Goldman,et al.  Cost-Effectiveness and Population Impact of Statins for Primary Prevention in Adults Aged 75 Years or Older in the United States , 2015, Annals of Internal Medicine.

[193]  A. Peters,et al.  Impact of smoking and smoking cessation on cardiovascular events and mortality among older adults: meta-analysis of individual participant data from prospective cohort studies of the CHANCES consortium , 2015, BMJ : British Medical Journal.

[194]  P. Wilson,et al.  Clinician-patient risk discussion for atherosclerotic cardiovascular disease prevention: importance to implementation of the 2013 ACC/AHA Guidelines. , 2015, Journal of the American College of Cardiology.

[195]  S. Selph,et al.  Screening for Abnormal Glucose and Type 2 Diabetes Mellitus: A Systematic Review to Update the 2008 U.S. Preventive Services Task Force Recommendation , 2015 .

[196]  Danielle M. Enserro,et al.  Implications of the US Cholesterol Guidelines on Eligibility for Statin Therapy in the Community: Comparison of Observed and Predicted Risks in the Framingham Heart Study Offspring Cohort , 2015, Journal of the American Heart Association.

[197]  T. Callister,et al.  A 15-Year Warranty Period for Asymptomatic Individuals Without Coronary Artery Calcium: A Prospective Follow-Up of 9,715 Individuals. , 2015, JACC. Cardiovascular imaging.

[198]  John W McEvoy,et al.  An analysis of calibration and discrimination among multiple cardiovascular risk scores in a modern multiethnic cohort. , 2015, Annals of internal medicine.

[199]  K. Rahimi,et al.  Blood pressure lowering in type 2 diabetes: a systematic review and meta-analysis. , 2015, JAMA.

[200]  M. Woodward,et al.  Effects of blood pressure reduction in mild hypertension: a systematic review and meta-analysis. , 2015, Annals of internal medicine.

[201]  M. Szklo,et al.  Social engagement and chronic disease risk behaviors: the Multi-Ethnic Study of Atherosclerosis. , 2015, Preventive medicine.

[202]  Andrew E Moran,et al.  Cost-effectiveness of hypertension therapy according to 2014 guidelines. , 2015, The New England journal of medicine.

[203]  D. Alter,et al.  Sedentary Time and Its Association With Risk for Disease Incidence, Mortality, and Hospitalization in Adults , 2015, Annals of Internal Medicine.

[204]  K. Shimada,et al.  Low-dose aspirin for primary prevention of cardiovascular events in Japanese patients 60 years or older with atherosclerotic risk factors: a randomized clinical trial. , 2014, JAMA.

[205]  G. Parati,et al.  Effects of blood pressure lowering on outcome incidence in hypertension: 2. Effects at different baseline and achieved blood pressure levels – overview and meta-analyses of randomized trials , 2014, Journal of hypertension.

[206]  N. Cook,et al.  Further insight into the cardiovascular risk calculator: the roles of statins, revascularizations, and underascertainment in the Women's Health Study. , 2014, JAMA internal medicine.

[207]  J. Wilding,et al.  Identification, assessment, and management of overweight and obesity: summary of updated NICE guidance , 2014, BMJ : British Medical Journal.

[208]  Yongping Xu,et al.  Effects of Mediterranean-style diet on glycemic control, weight loss and cardiovascular risk factors among type 2 diabetes individuals: a meta-analysis , 2014, European Journal of Clinical Nutrition.

[209]  K. Ethier,et al.  CDC National Health Report: leading causes of morbidity and mortality and associated behavioral risk and protective factors--United States, 2005-2013. , 2014, MMWR supplements.

[210]  M. Budoff,et al.  Significance of a positive family history for coronary heart disease in patients with a zero coronary artery calcium score (from the Multi-Ethnic Study of Atherosclerosis). , 2014, The American journal of cardiology.

[211]  D. Goff,et al.  Electronic Cigarettes: A Policy Statement From the American Heart Association , 2014, Circulation.

[212]  D. Goff,et al.  A systematic examination of the 2013 ACC/AHA pooled cohort risk assessment tool for atherosclerotic cardiovascular disease. , 2014, Journal of the American College of Cardiology.

[213]  F. Kronenberg,et al.  Discrimination and net reclassification of cardiovascular risk with lipoprotein(a): prospective 15-year outcomes in the Bruneck Study. , 2014, Journal of the American College of Cardiology.

[214]  C. Mangione,et al.  Primary care-based, pharmacist-physician collaborative medication-therapy management of hypertension: a randomized, pragmatic trial. , 2014, Clinical therapeutics.

[215]  M. Woodward,et al.  Blood pressure-lowering treatment based on cardiovascular risk: a meta-analysis of individual patient data , 2014, The Lancet.

[216]  Majid Ezzati,et al.  Global sodium consumption and death from cardiovascular causes. , 2014, The New England journal of medicine.

[217]  I. Piña,et al.  Status of Cardiovascular Disease and Stroke in Hispanics/Latinos in the United States: A Science Advisory From the American Heart Association , 2014, Circulation.

[218]  S. de Lusignan,et al.  Peripheral neuropathy and the risk of cardiovascular events in type 2 diabetes mellitus , 2014, Heart.

[219]  R. de Caterina,et al.  Aspirin therapy in primary cardiovascular disease prevention: a position paper of the European Society of Cardiology working group on thrombosis. , 2014, Journal of the American College of Cardiology.

[220]  R. Lamuela-Raventós,et al.  A provegetarian food pattern and reduction in total mortality in the Prevención con Dieta Mediterránea (PREDIMED) study. , 2014, The American journal of clinical nutrition.

[221]  Anilkrishna B. Thota,et al.  Team-based care and improved blood pressure control: a community guide systematic review. , 2014, American journal of preventive medicine.

[222]  Robert F Kushner,et al.  2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. , 2014, Journal of the American College of Cardiology.

[223]  Jennifer G. Robinson,et al.  2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. , 2014, Circulation.

[224]  Jennifer G. Robinson,et al.  2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines , 2014, Circulation.

[225]  G. Fonarow,et al.  ACC/AHA statement on cost/value methodology in clinical practice guidelines and performance measures: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and Task Force on Practice Guidelines. , 2014, Circulation.

[226]  A. Subar,et al.  Higher diet quality is associated with decreased risk of all-cause, cardiovascular disease, and cancer mortality among older adults. , 2014, The Journal of nutrition.

[227]  S. Tsimikas,et al.  The severe hypercholesterolemia phenotype: clinical diagnosis, management, and emerging therapies. , 2014, Journal of the American College of Cardiology.

[228]  M. Budoff,et al.  Use of Coronary Artery Calcium Testing to Guide Aspirin Utilization for Primary Prevention: Estimates From the Multi-Ethnic Study of Atherosclerosis , 2014, Circulation. Cardiovascular quality and outcomes.

[229]  A. Bauman,et al.  Review of the epidemiological evidence for physical activity and health from low- and middle-income countries , 2014, Global public health.

[230]  Adam T. Perzynski,et al.  Effectiveness and Safety of Patient Activation Interventions for Adults with Type 2 Diabetes: Systematic Review, Meta-Analysis, and Meta-regression , 2014, Journal of General Internal Medicine.

[231]  O. Franco,et al.  Comparison of application of the ACC/AHA guidelines, Adult Treatment Panel III guidelines, and European Society of Cardiology guidelines for cardiovascular disease prevention in a European cohort. , 2014, JAMA.

[232]  Mary Cushman,et al.  Validation of the atherosclerotic cardiovascular disease Pooled Cohort risk equations. , 2014, JAMA.

[233]  M. Grandner Addressing sleep disturbances: An opportunity to prevent cardiometabolic disease? , 2014, International review of psychiatry.

[234]  F. Hu,et al.  Added sugar intake and cardiovascular diseases mortality among US adults. , 2014, JAMA internal medicine.

[235]  Jbs Board Joint British Societies’ consensus recommendations for the prevention of cardiovascular disease (JBS3) , 2014, Heart.

[236]  J. Cutler,et al.  Outcomes of Combined Cardiovascular Risk Factor Management Strategies in Type 2 Diabetes: The ACCORD Randomized Trial , 2014, Diabetes Care.

[237]  N. Smart,et al.  Isometric exercise training for blood pressure management: a systematic review and meta-analysis. , 2014, Mayo Clinic proceedings.

[238]  Juned Siddique,et al.  Blood pressure trajectories in early adulthood and subclinical atherosclerosis in middle age. , 2014, JAMA.

[239]  P. Whelton,et al.  Health effects of sodium and potassium in humans , 2014, Current opinion in lipidology.

[240]  G. Lippi,et al.  E-Cigarettes and Cardiovascular Risk: Beyond Science and Mysticism , 2013, Seminars in Thrombosis & Hemostasis.

[241]  M. Szklo,et al.  Heart Disease in Patients With a Zero Coronary Artery Calcium Score (from the Multi-Ethnic Study of Atherosclerosis) , 2014 .

[242]  B. Lushniak,et al.  The Health consequences of smoking—50 years of progress : a report of the Surgeon General , 2014 .

[243]  S. Yanovski,et al.  Long-term drug treatment for obesity: a systematic and clinical review. , 2014, JAMA.

[244]  L. Shaw,et al.  ACC/AHA statement on cost/value methodology in clinical practice guidelines and performance measures: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and Task Force on Practice Guidelines. , 2014, Journal of the American College of Cardiology.

[245]  W. Willett,et al.  Association of nut consumption with total and cause-specific mortality. , 2013, The New England journal of medicine.

[246]  J. Saavedra,et al.  Effects of exercise on resting blood pressure in obese children: a meta‐analysis of randomized controlled trials , 2013, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[247]  José Agustín Arguedas,et al.  Blood pressure targets for hypertension in people with diabetes mellitus. , 2013, The Cochrane database of systematic reviews.

[248]  R. Warren,et al.  Incidence of cardiovascular disease in individuals with psoriasis: a systematic review and meta-analysis. , 2013, The Journal of investigative dermatology.

[249]  S. Gudbjörnsdottir,et al.  Albuminuria and renal function as predictors of cardiovascular events and mortality in a general population of patients with type 2 diabetes: A nationwide observational study from the Swedish National Diabetes Register , 2013, Diabetes & vascular disease research.

[250]  H. Tighiouart,et al.  Effects of intensive blood pressure lowering on the progression of chronic kidney disease: a systematic review and meta-analysis , 2013, Canadian Medical Association Journal.

[251]  J. Manson,et al.  Changes in red meat consumption and subsequent risk of type 2 diabetes mellitus: three cohorts of US men and women. , 2013, JAMA internal medicine.

[252]  Scott B Going,et al.  Relationship of sedentary behavior and physical activity to incident cardiovascular disease: results from the Women's Health Initiative. , 2013, Journal of the American College of Cardiology.

[253]  V. Beral,et al.  Coronary heart disease incidence in women by waist circumference within categories of body mass index , 2013, European journal of preventive cardiology.

[254]  K. Lavoie,et al.  The evolution of a Canadian Hypertension Education Program recommendation: the impact of resistance training on resting blood pressure in adults as an example. , 2013, The Canadian journal of cardiology.

[255]  M. Ernst,et al.  Physician‐Pharmacist Co‐Management and 24‐Hour Blood Pressure Control , 2013, Journal of clinical hypertension.

[256]  Yue Cao,et al.  Intake of trans fat and all-cause mortality in the Reasons for Geographical and Racial Differences in Stroke (REGARDS) cohort. , 2013, The American journal of clinical nutrition.

[257]  S. Lai,et al.  Effects of Metformin Versus Glipizide on Cardiovascular Outcomes in Patients With Type 2 Diabetes and Coronary Artery Disease , 2013, Diabetes Care.

[258]  Lee Hooper,et al.  Effect of increased potassium intake on cardiovascular risk factors and disease: systematic review and meta-analyses , 2013, BMJ : British Medical Journal.

[259]  P. Elliott,et al.  Effect of lower sodium intake on health: systematic review and meta-analyses , 2013, BMJ : British Medical Journal.

[260]  G. MacGregor,et al.  Effect of longer term modest salt reduction on blood pressure: Cochrane systematic review and meta-analysis of randomised trials , 2013, BMJ : British Medical Journal.

[261]  K. Knutson Sociodemographic and cultural determinants of sleep deficiency: implications for cardiometabolic disease risk. , 2013, Social science & medicine.

[262]  V. Cornelissen,et al.  Exercise Training for Blood Pressure: A Systematic Review and Meta‐analysis , 2013, Journal of the American Heart Association.

[263]  A. Goto,et al.  Low-Carbohydrate Diets and All-Cause Mortality: A Systematic Review and Meta-Analysis of Observational Studies , 2013, PloS one.

[264]  Prabhat Jha,et al.  21st-century hazards of smoking and benefits of cessation in the United States. , 2013, The New England journal of medicine.

[265]  W. Alpert Cardiovascular Effects of Intensive Lifestyle Intervention in Type 2 Diabetes , 2013 .

[266]  Michael D. Jensen,et al.  Reprint: 2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults. , 2013, Journal of the American Pharmacists Association : JAPhA.

[267]  Deepak L. Bhatt,et al.  2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2013, Circulation.

[268]  M. Postma,et al.  Primary Prevention of Major Cardiovascular and Cerebrovascular Events with Statins in Diabetic Patients , 2012, Drugs.

[269]  Lihui Zhao,et al.  Lifetime risk and years lived free of total cardiovascular disease. , 2012, JAMA.

[270]  David M Herrington,et al.  Early menopause predicts future coronary heart disease and stroke: the Multi-Ethnic Study of Atherosclerosis , 2012, Menopause.

[271]  M. Woodward,et al.  Effects of blood pressure lowering on cardiovascular outcomes in different cardiovascular risk groups among participants with type 2 diabetes. , 2012, Diabetes research and clinical practice.

[272]  U. Nöthlings,et al.  Dietary Fiber, Carbohydrate Quality and Quantity, and Mortality Risk of Individuals with Diabetes Mellitus , 2012, PloS one.

[273]  R. Collins,et al.  The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials , 2012, The Lancet.

[274]  S. Blair,et al.  Effect of physical inactivity on major non-communicable diseases worldwide: an analysis of burden of disease and life expectancy , 2012, BDJ.

[275]  M. Dowda,et al.  Independent Association of Waist Circumference With Hypertension and Diabetes in African American Women, South Carolina, 2007–2009 , 2012, Preventing chronic disease.

[276]  Edward H Ip,et al.  Lifestyle change and mobility in obese adults with type 2 diabetes. , 2012, The New England journal of medicine.

[277]  S. Sutton,et al.  Effectiveness of physical activity promotion based in primary care: systematic review and meta-analysis of randomised controlled trials , 2012, BMJ : British Medical Journal.

[278]  N. Wong,et al.  Global cardiovascular disease risk assessment in United States adults with diabetes , 2012, Diabetes & vascular disease research.

[279]  B. Gersh Dose Response Between Physical Activity and Risk of Coronary Heart Disease: A Meta-Analysis , 2012 .

[280]  M. Burtscher Lifetime risks of cardiovascular disease. , 2012, The New England journal of medicine.

[281]  G. Jürgens,et al.  Effects of low-sodium diet vs. high-sodium diet on blood pressure, renin, aldosterone, catecholamines, cholesterol, and triglyceride (Cochrane Review). , 2012, American journal of hypertension.

[282]  J. Pell,et al.  Meta-analysis of the association between secondhand smoke exposure and stroke. , 2011, Journal of public health.

[283]  A. Kengne,et al.  Body mass index, waist circumference and waist–hip ratio: which is the better discriminator of cardiovascular disease mortality risk? Evidence from an individual‐participant meta‐analysis of 82 864 participants from nine cohort studies , 2011, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[284]  Lora E Burke,et al.  Value of primordial and primary prevention for cardiovascular disease: a policy statement from the American Heart Association. , 2011, Circulation.

[285]  I-Min Lee,et al.  Dose Response Between Physical Activity and Risk of Coronary Heart Disease: A Meta-Analysis , 2011, Circulation.

[286]  D. Roter,et al.  A Randomized Trial to Improve Patient-Centered Care and Hypertension Control in Underserved Primary Care Patients , 2011, Journal of General Internal Medicine.

[287]  G. Mancia,et al.  Effects of intensive blood pressure reduction on myocardial infarction and stroke in diabetes: a meta-analysis in 73 913 patients , 2011, Journal of hypertension.

[288]  David M. Eddy,et al.  Individualized Guidelines: The Potential for Increasing Quality and Reducing Costs , 2011, Annals of Internal Medicine.

[289]  C. Furberg,et al.  A Meta-Analysis of Low-Density Lipoprotein Cholesterol, Non-High-Density Lipoprotein Cholesterol, and Apolipoprotein B as Markers of Cardiovascular Risk , 2011, Circulation. Cardiovascular quality and outcomes.

[290]  Amy Earley,et al.  Systematic Review: Blood Pressure Target in Chronic Kidney Disease and Proteinuria as an Effect Modifier , 2011, Annals of Internal Medicine.

[291]  K. Reynolds,et al.  Antihypertensive Treatment and Secondary Prevention of Cardiovascular Disease Events Among Persons Without Hypertension: A Meta-Analysis , 2012 .

[292]  M. Woodward,et al.  The effects of blood pressure reduction and of different blood pressure-lowering regimens on major cardiovascular events according to baseline blood pressure: meta-analysis of randomized trials , 2011, Journal of hypertension.

[293]  M. Taskinen,et al.  [ESC/EAS Guidelines for the management of dyslipidaemias]. , 2011, Revista espanola de cardiologia.

[294]  Neil M. Johannsen,et al.  Effects of aerobic and resistance training on hemoglobin A1c levels in patients with type 2 diabetes: a randomized controlled trial. , 2010, JAMA.

[295]  R. Collins,et al.  Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials , 2010, The Lancet.

[296]  A. Khera,et al.  Body size misperception: a novel determinant in the obesity epidemic. , 2010, Archives of internal medicine.

[297]  L. Diep,et al.  Association of physical activity level and stroke outcomes in men and women: a meta-analysis. , 2010, Journal of women's health.

[298]  A. Tonkin,et al.  Best practice for prevention and treatment of cardiovascular disease through an equity lens: a review , 2010, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[299]  J. Graff Zivin,et al.  US Pharmacists' Effect as Team Members on Patient Care: Systematic Review and Meta-Analyses , 2010, Medical care.

[300]  W. Willett,et al.  Effects of the Dietary Approaches to Stop Hypertension (DASH) Eating Plan on Cardiovascular Risks Among Type 2 Diabetic Patients , 2010, Diabetes Care.

[301]  Keith C. Norris,et al.  Intensive blood-pressure control in hypertensive chronic kidney disease. , 2010, The New England journal of medicine.

[302]  R. Palmer,et al.  Participatory Decision Making, Patient Activation, Medication Adherence, and Intermediate Clinical Outcomes in Type 2 Diabetes: A STARNet Study , 2010, The Annals of Family Medicine.

[303]  JoAnn E. Manson,et al.  Coronary Heart Disease Major Dietary Protein Sources and Risk of Coronary Heart Disease in Women , 2017 .

[304]  D. Hessler,et al.  Using the Teamlet Model to Improve Chronic Care in an Academic Primary Care Practice , 2010, Journal of General Internal Medicine.

[305]  Robert J Glynn,et al.  Body mass index, waist circumference, and risk of coronary heart disease: A prospective study among men and women. , 2010, Obesity research & clinical practice.

[306]  Mary Cushman,et al.  Aspirin for Primary Prevention of Cardiovascular Events in People With Diabetes: A Position Statement of the American Diabetes Association, a Scientific Statement of the American Heart Association, and an Expert Consensus Document of the American College of Cardiology Foundation , 2010, Circulation.

[307]  Dariush Mozaffarian,et al.  Red and Processed Meat Consumption and Risk of Incident Coronary Heart Disease, Stroke, and Diabetes Mellitus: A Systematic Review and Meta-Analysis , 2010, Circulation.

[308]  Kevin A Peterson,et al.  Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus , 2011 .

[309]  P. Sandercock,et al.  Aspirin for prevention of cardiovascular events in a general population screened for a low ankle brachial index: a randomized controlled trial. , 2010, JAMA.

[310]  D. Mozaffarian,et al.  Defining and Setting National Goals for Cardiovascular Health Promotion and Disease Reduction: The American Heart Association's Strategic Impact Goal Through 2020 and Beyond , 2010, Circulation.

[311]  P. Lin,et al.  Effects of the DASH diet alone and in combination with exercise and weight loss on blood pressure and cardiovascular biomarkers in men and women with high blood pressure: the ENCORE study. , 2010, Archives of internal medicine.

[312]  Michael E. Miller,et al.  ACTION TO CONTROL CARDIOVASCULAR RISK IN DIABETES STUDY GROUP. EFFECTS OF INTENSIVE GLUCOSE LOWERING IN TYPE 2 DIABETES , 2010 .

[313]  Karin Kraft,et al.  [Type-2 diabetes]. , 2010, MMW Fortschritte der Medizin.

[314]  Shimin Zheng,et al.  The potency of team-based care interventions for hypertension: a meta-analysis. , 2009, Archives of internal medicine.

[315]  Nancy K Latham,et al.  Progressive resistance strength training for improving physical function in older adults. , 2009, The Cochrane database of systematic reviews.

[316]  Michael J. Pencina,et al.  Predicting the 30-Year Risk of Cardiovascular Disease: The Framingham Heart Study , 2009, Circulation.

[317]  R. Collins,et al.  Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials , 2009, The Lancet.

[318]  N. Sattar,et al.  Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials , 2009, The Lancet.

[319]  N J Wald,et al.  Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies , 2009, BMJ : British Medical Journal.

[320]  D. Mozaffarian,et al.  Trans fatty acids: effects on metabolic syndrome, heart disease and diabetes , 2009, Nature Reviews Endocrinology.

[321]  G. Boysen,et al.  European Guidelines on Cardiovascular Disease Prevention , 2009, International journal of stroke : official journal of the International Stroke Society.

[322]  K. Winkley,et al.  An updated meta-analysis to assess the effectiveness of psychological interventions delivered by psychological specialists and generalist clinicians on glycaemic control and on psychological status. , 2009, Patient education and counseling.

[323]  D. Mozaffarian,et al.  The Preventable Causes of Death in the United States: Comparative Risk Assessment of Dietary, Lifestyle, and Metabolic Risk Factors , 2009, PLoS medicine.

[324]  Nicola Orsini,et al.  Quantifying the dose-response of walking in reducing coronary heart disease risk: meta-analysis , 2009, European Journal of Epidemiology.

[325]  R. Collins,et al.  Statin Cost-Effectiveness in the United States for People at Different Vascular Risk Levels , 2009, Circulation. Cardiovascular quality and outcomes.

[326]  Grant D. Huang,et al.  Glucose control and vascular complications in veterans with type 2 diabetes. , 2009, The New England journal of medicine.

[327]  N. Grossblatt Secondhand Smoke Exposure and Cardiovascular Effects : Making Sense of the Evidence , 2009 .

[328]  F. McAlister,et al.  A randomized trial of the effect of community pharmacist and nurse care on improving blood pressure management in patients with diabetes mellitus: study of cardiovascular risk intervention by pharmacists-hypertension (SCRIP-HTN). , 2008, Archives of internal medicine.

[329]  P. Libby,et al.  Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. , 2008, The New England journal of medicine.

[330]  T. Morimoto,et al.  Low-Dose Aspirin for Primary Prevention of Atherosclerotic Events in Patients With Type 2 Diabetes , 2012 .

[331]  J. Witteman,et al.  Efficacy of statins in familial hypercholesterolaemia: a long term cohort study , 2008, BMJ : British Medical Journal.

[332]  N. Paynter,et al.  C-Reactive Protein and Parental History Improve Global Cardiovascular Risk Prediction: The Reynolds Risk Score for Men , 2008, Circulation.

[333]  P. Macfarlane,et al.  The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease , 2008, BMJ : British Medical Journal.

[334]  P. Miller,et al.  Blood pressure reduction during treatment for alcohol dependence: results from the Combining Medications and Behavioral Interventions for Alcoholism (COMBINE) study. , 2008, Addiction.

[335]  Daniel Touchette,et al.  A Randomized Controlled Trial of Team-Based Care: Impact of Physician-Pharmacist Collaboration on Uncontrolled Hypertension , 2008, Journal of General Internal Medicine.

[336]  R. R. Wolfe,et al.  The danger of weight loss in the elderly , 2008, The journal of nutrition, health & aging.

[337]  M. Böhm,et al.  The PHARAO study: prevention of hypertension with the angiotensin-converting enzyme inhibitor ramipril in patients with high-normal blood pressure – a prospective, randomized, controlled prevention trial of the German Hypertension League , 2008, Journal of hypertension.

[338]  S. Soedamah-Muthu,et al.  Risk of myocardial infarction in men and women with type 2 diabetes in the UK: a cohort study using the General Practice Research Database , 2008, Diabetologia.

[339]  Rosanna Abbate,et al.  Physical activity during leisure time and primary prevention of coronary heart disease: an updated meta-analysis of cohort studies , 2008, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[340]  M. Pencina,et al.  General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study , 2008, Circulation.

[341]  E. Michelson,et al.  TROPHY study: Outcomes based on the Seventh Report of the Joint National Committee on Hypertension definition of hypertension. , 2008, Journal of the American Society of Hypertension : JASH.

[342]  M. Hamer,et al.  Walking and primary prevention: a meta-analysis of prospective cohort studies , 2007, British Journal of Sports Medicine.

[343]  D. Coyle,et al.  Effects of Aerobic Training, Resistance Training, or Both on Glycemic Control in Type 2 Diabetes , 2007, Annals of Internal Medicine.

[344]  S. Kalra,et al.  EXERCISE AND ACUTE CARDIOVASCULAR EVENTS: PLACING THE RISKS INTO PERSPECTIVE: A SCIENTIFIC STATEMENT FROM THE AMERICAN HEART ASSOCIATION COUNCIL ON NUTRITION, PHYSICAL ACTIVITY, AND METABOLISM AND THE COUNCIL ON CLINICAL CARDIOLOGY , 2007 .

[345]  A. Trichopoulou,et al.  Low-carbohydrate–high-protein diet and long-term survival in a general population cohort , 2007, European Journal of Clinical Nutrition.

[346]  N. Cook,et al.  Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the trials of hypertension prevention (TOHP) , 2007, BMJ : British Medical Journal.

[347]  Will G. Hopkins,et al.  Effects of Different Modes of Exercise Training on Glucose Control and Risk Factors for Complications in Type 2 Diabetic Patients: a Meta-Analysis , 2007, Diabetes Care.

[348]  N. Cook,et al.  Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score. , 2007, JAMA.

[349]  W. Hopkins,et al.  Effects of Different Modes of Exercise Training on Glucose Control and Risk Factors for Complications in Type 2 Diabetic Patients , 2006, Diabetes Care.

[350]  D. Mikhailidis,et al.  Efficacy and Safety of Atorvastatin in the Prevention of Cardiovascular End Points in Subjects With Type 2 Diabetes: The Atorvastatin Study for Prevention of Coronary Heart Disease Endpoints in Non-Insulin-Dependent Diabetes Mellitus (ASPEN) , 2006, Diabetes Care.

[351]  Yasuo Ohashi,et al.  Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): a prospective randomised controlled trial , 2006, The Lancet.

[352]  L. Pbert,et al.  Smoking Prevention and Cessation Intervention Delivery by Pediatric Providers, as Assessed With Patient Exit Interviews , 2006, Pediatrics.

[353]  S. Yusuf,et al.  Tobacco use and risk of myocardial infarction in 52 countries in the INTERHEART study: a case-control study , 2006, The Lancet.

[354]  S. Pocock,et al.  Efficacy and Safety of Atorvastatin in the Prevention of Cardiovascular End Points in Subjects With Type 2 Diabetes , 2006, Diabetes Care.

[355]  S. Oparil,et al.  Feasibility of treating prehypertension with an angiotensin-receptor blocker. , 2006, The New England journal of medicine.

[356]  S. Soedamah-Muthu,et al.  High risk of cardiovascular disease in patients with type 1 diabetes in the U.K.: a cohort study using the general practice research database. , 2006, Diabetes care.

[357]  Ralph B D'Agostino,et al.  Prediction of Lifetime Risk for Cardiovascular Disease by Risk Factor Burden at 50 Years of Age , 2006, Circulation.

[358]  Bryan Williams,et al.  Lifestyle interventions to reduce raised blood pressure: a systematic review of randomized controlled trials , 2006, Journal of hypertension.

[359]  C. Samuel-Hodge,et al.  Achieving healthy weight in African-American communities: research perspectives and priorities. , 2005, Obesity research.

[360]  S. Kritchevsky,et al.  Weight change and the conservation of lean mass in old age: the Health, Aging and Body Composition Study. , 2005, The American journal of clinical nutrition.

[361]  R. Collins,et al.  Reduction in cardiovascular events with atorvastatin in 2,532 patients with type 2 diabetes: Anglo-Scandinavian Cardiac Outcomes Trial--lipid-lowering arm (ASCOT-LLA). , 2005, Diabetes care.

[362]  T. Harris,et al.  Health consequences of obesity in the elderly: a review of four unresolved questions , 2005, International Journal of Obesity.

[363]  F. Gueyffier,et al.  Treatment of High Blood Pressure and Gain in Event-Free Life Expectancy , 2005, Vascular health and risk management.

[364]  B. Hedblad,et al.  Prevalence and prognostic significance of asymptomatic peripheral arterial disease in 68-year-old men with diabetes. Results from the population study 'Men born in 1914' from Malmö, Sweden. , 2005, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[365]  J. Kaufman,et al.  Evaluating the evidence for models of life course socioeconomic factors and cardiovascular outcomes: a systematic review , 2005, BMC public health.

[366]  John H Fuller,et al.  Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial , 2004, The Lancet.

[367]  S. Rabe-Hesketh,et al.  Systematic review and meta-analysis of randomised controlled trials of psychological interventions to improve glycaemic control in patients with type 2 diabetes , 2004, The Lancet.

[368]  C. Nishida,et al.  Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies , 2004, The Lancet.

[369]  K. Lohr,et al.  Screening and Interventions for Obesity in Adults: Summary of the Evidence for the U.S. Preventive Services Task Force , 2003, Annals of Internal Medicine.

[370]  F. Biro,et al.  Different shapes in different cultures: body dissatisfaction, overweight, and obesity in African-American and caucasian females. , 2003, Journal of pediatric and adolescent gynecology.

[371]  Diederick E. Grobbee,et al.  Influence of Weight Reduction on Blood Pressure: A Meta-Analysis of Randomized Controlled Trials , 2003, Hypertension.

[372]  Lung High blood cholesterol. , 2003, Nutrition in clinical care : an official publication of Tufts University.

[373]  T. Fahey,et al.  The influence of absolute cardiovascular risk, patient utilities, and costs on the decision to treat hypertension: a Markov decision analysis , 2003, Journal of hypertension.

[374]  A. Dyer,et al.  Major Risk Factors as Antecedents of Fatal and Nonfatal Coronary Heart Disease Events , 2003 .

[375]  Christopher H Schmid,et al.  Progression of Chronic Kidney Disease: The Role of Blood Pressure Control, Proteinuria, and Angiotensin-Converting Enzyme Inhibition: A Patient-Level Meta-Analysis , 2003, Annals of Internal Medicine.

[376]  D. Grobbee,et al.  Blood pressure response to changes in sodium and potassium intake: a metaregression analysis of randomised trials , 2003, Journal of Human Hypertension.

[377]  Sarah Parish,et al.  MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial , 2003, The Lancet.

[378]  Victor J Stevens,et al.  Effects of comprehensive lifestyle modification on blood pressure control: main results of the PREMIER clinical trial. , 2003, JAMA.

[379]  Oluf Pedersen,et al.  Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. , 2003, The New England journal of medicine.

[380]  M. Munafo,et al.  Interventions for smoking cessation in hospitalised patients. , 2003, The Cochrane database of systematic reviews.

[381]  R. Collins,et al.  Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies , 2002, The Lancet.

[382]  Tom Greene,et al.  Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial. , 2002, JAMA.

[383]  D. Bennett,et al.  Blood pressure and coronary heart disease: a review of the evidence. , 2002, Seminars in vascular medicine.

[384]  James F Sallis,et al.  AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 Update: Consensus Panel Guide to Comprehensive Risk Reduction for Adult Patients Without Coronary or Other Atherosclerotic Vascular Diseases. American Heart Association Science Advisory and Coordinating Committee. , 2002, Circulation.

[385]  Jiang He,et al.  Effect of Aerobic Exercise on Blood Pressure , 2002, Annals of Internal Medicine.

[386]  A. Woods High blood pressure (hypertension). , 2002, Nursing.

[387]  S. Fowler,et al.  Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. , 2002 .

[388]  S. Hampson Randomised, placebo-controlled trial , 2002 .

[389]  R. Sigal,et al.  Effects of exercise on glycemic control and body mass in type 2 diabetes mellitus: a meta‐analysis of controlled clinical trials , 2002, JAMA.

[390]  G L Freeman,et al.  High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. , 2001, Arthritis and rheumatism.

[391]  Jiang He,et al.  Effects of Alcohol Reduction on Blood Pressure: A Meta-Analysis of Randomized Controlled Trials , 2001, Hypertension.

[392]  Glen P. Kenny,et al.  Effects of Exercise on Glycemic Control and Body Mass in Type 2 Diabetes Mellitus: A Meta-analysis of Controlled Clinical Trials , 2001 .

[393]  M. Yoshiyama,et al.  Acute effects of passive smoking on the coronary circulation in healthy young adults. , 2001, JAMA.

[394]  G. Bray,et al.  Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. , 2001, The New England journal of medicine.

[395]  T. Lancaster,et al.  Training health professionals in smoking cessation. , 2000, The Cochrane database of systematic reviews.

[396]  P. Priest,et al.  Using thresholds based on risk of cardiovascular disease to target treatment for hypertension: modelling events averted and number treated , 2000, BMJ : British Medical Journal.

[397]  Orton,et al.  EFFECTS ON BLOOD PRESSURE OF REDUCED DIETARY SODIUM AND THE DIETARY APPROACHES TO STOP HYPERTENSION ( DASH ) DIET , 2000 .

[398]  A clinical practice guideline for treating tobacco use and dependence: A US Public Health Service report. The Tobacco Use and Dependence Clinical Practice Guideline Panel, Staff, and Consortium Representatives. , 2000, JAMA.

[399]  R. Holman,et al.  Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group. , 1999, JAMA.

[400]  R. Holman,et al.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. , 1998 .

[401]  A. Gotto,et al.  Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study. , 1998, JAMA.

[402]  P. Whelton,et al.  Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly (TONE). TONE Collaborative Research Group. , 1998, JAMA.

[403]  P. Whelton,et al.  Effects of oral potassium on blood pressure. Meta-analysis of randomized controlled clinical trials. , 1997, JAMA.

[404]  G. Bray,et al.  A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. , 1997, The New England journal of medicine.

[405]  R. D'Agostino,et al.  Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study. , 1997, American journal of epidemiology.

[406]  N. Cook,et al.  Efficacy of nonpharmacologic interventions in adults with high-normal blood pressure: results from phase 1 of the Trials of Hypertension Prevention. Trials of Hypertension Prevention Collaborative Research Group. , 1997, The American journal of clinical nutrition.

[407]  Effects of weight loss and sodium reduction intervention on blood pressure and hypertension incidence in overweight people with high-normal blood pressure. The Trials of Hypertension Prevention, phase II. The Trials of Hypertension Prevention Collaborative Research Group. , 1997, Archives of internal medicine.

[408]  V. Nicaud,et al.  Improving hypertension control among excessive alcohol drinkers: a randomised controlled trial in France. The WALPA Group. , 1995, Journal of epidemiology and community health.

[409]  P. Macfarlane,et al.  Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. , 1995, The New England journal of medicine.

[410]  C. Lewis,et al.  Treatment of Mild Hypertension Study: Final Results , 1993 .

[411]  J. Cutler,et al.  Treatment of Mild Hypertension Study. Final results. Treatment of Mild Hypertension Study Research Group. , 1993, JAMA.

[412]  N. Cook,et al.  The Effects of Nonpharmacologic Interventions on Blood Pressure of Persons With High Normal Levels: Results of the Trials of Hypertension Prevention, Phase I , 1992 .

[413]  A. Haines,et al.  Randomised controlled trial of general practitioner intervention in patients with excessive alcohol consumption. , 1988, BMJ.

[414]  M. Wiewiórowska [Patients with diabetes mellitus]. , 1987, Pielegniarka i polozna.